AR and melanoma: Consistent with previous studies implicating AR in melanoma cell proliferation (Morvillo et al., 1995, 2002), the anti-androgen flutamide, which competes with androgen for binding to AR, significantly decreased melanoma cell proliferation (p < 0.0001; Figure S3A).